| Literature DB >> 29205944 |
Pavla Martinkova1,2, Martin Brtnicky2,3, Jindrich Kynicky2,3, Miroslav Pohanka1,3.
Abstract
Although cancer is one of the most dangerous and the second most lethal disease in the world, current therapy including surgery, chemotherapy, radiotherapy, etc., is highly insufficient not in the view of therapy success rate or the amount of side effects. Accordingly, procedures with better outcomes are highly desirable. Iron oxide nanoparticles (IONPs) present an innovative tool-ideal for innovation and implementation into practice. This review is focused on summarizing some well-known facts about pharmacokinetics, toxicity, and the types of IONPs, and furthermore, provides a survey of their use in cancer diagnosis and therapy.Entities:
Keywords: cancer; hyperthermia; iron oxide nanoparticles; magnetic resonance imagining; targeted drug delivery
Mesh:
Substances:
Year: 2017 PMID: 29205944 DOI: 10.1002/adhm.201700932
Source DB: PubMed Journal: Adv Healthc Mater ISSN: 2192-2640 Impact factor: 9.933